Chemical Structure (Eraxis 01)
Chemical structure diagram of anidulafungin, the active ingredient in ERAXIS injection powder, lyophilized, for solution.*
Eraxis Injection, Powder, Lyophilized, For Solution
Product Images NDC 0049-0114
6 FDA label images from Roerig · Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Eraxis (NDC 0049-0114). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Roerig, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Logo (Eraxis 02)
Label panel for ERAXIS injection distributed by Roerig, a division of Pfizer Inc, located in New York, NY. The label shows the Pfizer logo and distributor information. ERAXIS contains anidulafungin as its active ingredient in a lyophilized powder form for intravenous injection.*
Principal Display Panel (50 mg Vial Label)
Label for Eraxis (anidulafungin) Injection, 50 mg per vial, a lyophilized powder for intravenous infusion. The label notes storage instructions to refrigerate at 2-8°C and detailed reconstitution directions with sterile water. It is distributed by Roerig, a division of Pfizer Inc.*
Principal Display Panel (50 mg Vial Carton)
Packaging label for Erais (anidulafungin) injection, powder, lyophilized for solution, 50 mg per vial, intended for intravenous infusion only. The carton indicates storage at 2°-8°C (36°-46°F) without freezing. The labeler is Roerig, a division of Pfizer Inc. The label includes a detailed reconstitution instruction panel and lists inactive ingredients per vial.*
Principal Display Panelpanel (100 mg Vial Label)
Label for ERAxis (anidulafungin) injection, powder, lyophilized for solution. It is a 100 mg sterile single-dose vial for intravenous infusion only. The label includes storage instructions to refrigerate at 2-8°C and cautions not to freeze. The vial must be reconstituted with 30 mL sterile water before use. Distributed by Roerig, Division of Pfizer Inc.*
Principal Display Panel (100 mg Vial Carton)
Carton label for Erais (anidulafungin) injection 100 mg/vial, a lyophilized powder for intravenous infusion. The label states storage instructions to keep the vial refrigerated at 2-8°C (36-46°F) and not to freeze. It includes directions for reconstitution with 30 mL sterile water and further dilution instructions, and identifies Roerig, a division of Pfizer Inc., as the labeler. The label also shows ingredient details and a barcode.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
